Tomlinson B, Chan J Cn, Chan W B, Chen W Wc, Chow F Cc, Li S K, Kong A Ps, Ma R Cw, Siu D Cw, Tan K Cb, Wong L Ks, Yeung V Tf, But B Wm, Cheung P T, Fu C C, Tung J Yl, Wong W C, Yau H C
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.
Qualigenics Diabetes Centre, Hong Kong.
Hong Kong Med J. 2018 Aug;24(4):408-415. doi: 10.12809/hkmj187215.
In 2016, meetings of groups of physicians and paediatricians with a special interest in lipid disorders and familial hypercholesterolaemia were held to discuss several domains of management of familial hypercholesterolaemia in adults and children in Hong Kong. After reviewing the evidence and guidelines for the diagnosis, screening, and management of familial hypercholesterolaemia, consensus was reached on the following aspects: clinical features, diagnostic criteria, screening in adults, screening in children, management in relation to target plasma low-density lipoprotein cholesterol levels, detection of atherosclerosis, lifestyle and behaviour modification, and pharmacotherapy.
2016年,针对脂质紊乱和家族性高胆固醇血症有着特殊兴趣的内科医生和儿科医生团体召开了会议,以讨论香港成人和儿童家族性高胆固醇血症管理的几个领域。在回顾了家族性高胆固醇血症诊断、筛查及管理的证据和指南后,就以下方面达成了共识:临床特征、诊断标准、成人筛查、儿童筛查、与目标血浆低密度脂蛋白胆固醇水平相关的管理、动脉粥样硬化检测、生活方式和行为改变以及药物治疗。